L.J. Esserman
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
-
- Cancer Genomics and Diagnostics 3
- Breast Cancer Treatment Studies 2
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Kelloff Gj (1 shared paper)DA Berry (1 shared paper)NM Hylton (1 shared paper)Zoran Antonijevic (1 shared paper)Robert A. Beckman (1 shared paper)Ernest C. Borden (1 shared paper)Michael Joseph Campbell (1 shared paper)Subha Madhavan (1 shared paper)
- Journals
- ESMO Open (2 papers)Cancer Research (2 papers)Annals of Oncology (2 papers)European Journal of Cancer (2 papers)Clinical Pharmacology & Therapeutics (2 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
L.J. Esserman
13 papers receiving 712 citations
L.J. Esserman's Hit Papers
Peers
Comparison fields: 5 of 83
- Statistics and Probability 223
- Cancer Research 234
- Oncology 134
- Management Science and Operations Research 55
- Economics and Econometrics 100
Countries citing papers authored by L.J. Esserman
This map shows the geographic impact of L.J. Esserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.J. Esserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.J. Esserman more than expected).
Fields of papers citing papers by L.J. Esserman
This network shows the impact of papers produced by L.J. Esserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.J. Esserman. The network helps show where L.J. Esserman may publish in the future.
Co-authors
The 25 scholars most cited alongside L.J. Esserman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy Hit paper breakdown → | 2009 | 596 |
| 2 | 1995 | 87 | |
| 3 | 2016 | 32 | |
| 4 | Biological therapies for breast carcinoma: concepts for improvement in survival. | 1999 | 15 |
| 5 | 2014 | 9 | |
| 6 | 2016 | 5 | |
| 7 | 2024 | 3 | |
| 8 | 2011 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2011 | 1 | |
| 13 | 2002 | 1 | |
| 14 | 2025 | 0 |
About L.J. Esserman
L.J. Esserman is a scholar working on Cancer Research, Immunology, Oncology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 14 papers that have together received 755 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Medical Imaging Techniques and Applications (2 papers), Immunotherapy and Immune Responses (2 papers), Breast Implant and Reconstruction (2 papers), Breast Lesions and Carcinomas (2 papers), Breast Cancer Treatment Studies (2 papers), MRI in cancer diagnosis (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Statistics and Probability (223 citations), Cancer Research (234 citations), Oncology (134 citations), Management Science and Operations Research (55 citations) and Economics and Econometrics (100 citations). L.J. Esserman has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Kelloff Gj, DA Berry, NM Hylton, Zoran Antonijevic, Robert A. Beckman, Ernest C. Borden, Michael Joseph Campbell, Subha Madhavan, John W. Loewy and Amy M. Fulton. Their work appears in journals such as ESMO Open, Cancer Research, Annals of Oncology, European Journal of Cancer and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.